Skip to content
Menu

Zymeworks Inc. ZYME

Full chart Compare
Set alert

Price alert · ZYME

All alert types
26.14 USD -0.72 (-2.68%)

Regular-session close

26.14 0.00 0.00%

After hours · Nov 20, 4:00 PM ET

26.09 Day range 27.56
21.52 52-week range 31.97
YTD
-0.72%
1 year
+9.74%

Held by funds

95 US ETFs and mutual funds hold ZYME · largest positions

  1. VTI 0.00% of fund $34.77M
  2. IWM 0.04% of fund $31.12M
  3. NJM 0.04% of fund $28.70M
  4. FSSNX 0.04% of fund $15.13M
  5. IBB 0.13% of fund $14.01M
  6. IWO 0.08% of fund $11.17M
  7. FIDGX 0.12% of fund $10.86M
  8. NLO 0.07% of fund $10.01M
  9. DFAS 0.03% of fund $8.17M
  10. VTWO 0.04% of fund $7.68M
  11. BDSKX 0.12% of fund $6.36M
  12. FESM 0.07% of fund $4.50M
  13. VHT 0.01% of fund $3.53M
  14. IJE 0.22% of fund $3.14M
  15. FBIOX 0.05% of fund $3.04M
  16. DFMC 0.04% of fund $2.93M
  17. CANC 1.36% of fund $2.73M
  18. MDSKX 0.04% of fund $2.40M
  19. DFAC 0.00% of fund $2.26M
  20. SPDW 0.01% of fund $2.19M

Ownership

Held by insiders 1.35%
Held by institutions 105.69%
Float held by institutions 107.13%
Institutions 307

Top institutional holders

Top institutional holders
Holder% heldSharesValueReported
EcoR1 Capital, LLC36.46%22,970,388600.45MSep 29, 2026
Rubric Capital Management LP11.11%7,000,000182.98MSep 29, 2026
Blackrock Inc.6.69%4,212,745110.12MSep 29, 2026
Perceptive Advisors Llc5.63%3,545,50192.68MSep 29, 2026
BVF Inc.5.50%3,464,14290.55MSep 29, 2026
Morgan Stanley5.14%3,236,91584.61MSep 29, 2026

Top mutual fund holders

Top mutual fund holders
Holder% heldSharesValueReported
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund2.39%1,508,61339.44MJun 29, 2026
iShares Trust-iShares Russell 2000 ETF1.88%1,185,92831.00MSep 29, 2026
IVY FUNDS-Nomura Small Cap Growth Fund0.95%600,84615.71MJun 29, 2026
iShares Trust-iShares Biotechnology ETF0.85%538,11014.07MSep 29, 2026
Fidelity Salem Street Trust-Fidelity Small Cap Index Fund0.82%514,48413.45MAug 30, 2026
iShares Trust-iShares Russell 2000 Growth ETF0.68%425,94911.13MSep 29, 2026

Included in Plus and up

Sign in to see Institutional ownership

How much funds own from their 13F filings, quarter by quarter, and the largest holders.

Free with an account

Sign in to see Insider activity

Two years of insider buying and selling by month, marked on the price.

Included in Plus and up

Sign in to see Congress trading

Every stock trade disclosed by members of the US Senate and House.

Leadership team

Who runs ZYME, and what each was last paid

Kenneth H. Galbraith, Chairman of the Board, Chief Executive Officer & PresidentAverage age 52

ZYME key executives
NameTitlePayAge
Kenneth H. GalbraithChairman of the Board, Chief Executive Officer & President$1.71M 64
Paul MooreChief Scientific Officer$998K 59
Paul R. SchneiderExecutive VP & General Counsel— 55
Stuart KnightExecutive VP & Chief Information Officer— —
Mark HollywoodExecutive VP & Chief Operating Officer— 57
Scott PlatshonExecutive VP & Chief Business Officer— 35
Bijal DesaiSenior Vice President of Finance— —
Diana PapoveVice President of Corporate Communications— —
Kristin StaffordExecutive VP & CFO— 44
Laura O'ConnorSenior VP & Chief Human Resources Officer— —
Shrinal InamdarVice President of Investor Relations— —
Suzanne MonahanSenior VP of Commercial & GM of Theravance Biopharma— —

Pay is the latest total FMP has for each person (salary, bonus, stock and other awards) and can lag the newest proxy statement. Source: Financial Modeling Prep, from the company’s SEC filings.

Free with an account

Sign in to see CEO compensation

What the chief executive was paid each year, by salary, bonus and stock, beside the company's earnings.

Free with an account

Sign in to see Board of directors

Who sits on the board, who chairs it, and how long each director has served.

ZYME insiders
InsiderRelationLatest transactionDateShares held
CIONGOLI GREGORY AUSTINDirectorStock Award(Grant)Aug 11, 2025493,500
ECOR1 CAPITAL, L.L.C.Beneficial Owner of more than 10% of a Class of SecurityConversion of Exercise of derivative securityJun 25, 20250
GALBRAITH KENNETH HARRYChief Executive OfficerSaleJan 11, 2026226,842
HOLLYWOOD MARKChief Operating OfficerStock Award(Grant)Jul 5, 2026133,852
MOORE PAUL ANDREWOfficerSaleNov 12, 202633,756
PATTERSON LEONE D. CPAChief Financial OfficerStock Award(Grant)Jan 5, 2026459